HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of PJOV56, a new quinoxalinyl-hydrazone derivative able to induce autophagy and apoptosis in colorectal cancer cells, and related compounds.

Abstract
Quinoxaline derivatives are reported as antineoplastic agents against a variety of human cancer cell lines, with some compounds being submitted to clinical trials. In this work, we report the synthesis, characterization and cytotoxicity potential of a new series of quinoxalinyl-hydrazones. The most cytotoxic compound was (E)-2-[2-(2-pyridin-2-ylmethylene)hydrazinyl]quinoxaline (PJOV56) that presented a time-dependent effect against HCT-116 cells. After 48 h of incubation, PJOV56 was able to induce autophagy and apoptosis of HCT-116 cells, mediated by upregulation of Beclin 1, upregulation of LC3A/B II and activation of caspase 7. Apoptosis was induced along with G0/G1 cell cycle arrest at the highest concentration of PJOV56 (6.0 µM). Thus, PJOV56 showed a dose-dependent mode of action related to induction of autophagy and apoptosis in HCT-116 cells.
AuthorsSarah Sant'Anna Maranhão, Andrea Felinto Moura, Augusto César Aragão Oliveira, Daisy Jereissati Barbosa Lima, Francisco Washington Araújo Barros-Nepomuceno, Carlos Roberto Koscky Paier, Alessandra Campbell Pinheiro, Thais Cristina Mendonça Nogueira, Marcus Vinícius Nora de Souza, Claudia Pessoa
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 30 Issue 2 Pg. 126851 (01 15 2020) ISSN: 1464-3405 [Electronic] England
PMID31836446 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Ltd. All rights reserved.
Chemical References
  • Hydrazones
  • Quinoxalines
Topics
  • Apoptosis (drug effects)
  • Autophagy (drug effects)
  • Colorectal Neoplasms (drug therapy)
  • Humans
  • Hydrazones (chemical synthesis, chemistry)
  • Quinoxalines (chemical synthesis, chemistry)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: